Concepedia

Author

Robert Hayward

Institute of Cancer Research

Also Known As

Hayward, R., R H Hayward, R. Hayward, Robert Hayward, S. Muller

38

Publications

3.9K

Citations

19

H-Index

57

Concepts

All Affiliations

Institute of Cancer ResearchCancer Research UKKing's College LondonUniversity of LeicesterUniversity of Cambridge
RH

About

Robert Hayward is an author at Institute of Cancer Research specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

13

2.1K

2

Natural Sciences

4

4

315

3

Biochemistry

2

2

186

4

Engineering

1

1

86

5

Biomedical Engineering

1

1

86

Robert Hayward

×

23

Publications

3.9K

Citations

19

H-Index

YearCitations

<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors

Fei Su, Amaya Virós, Carla Milagre,

New England Journal of Medicine

2012

1K

Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice

Nathalie Dhomen, Jorge S. Reis‐Filho, Silvy da Rocha Dias,

Cancer Cell

2009

571

B-RAF is a therapeutic target in melanoma

Maria Karasarides, Antonio Chiloeches, Robert Hayward,

Oncogene

2004

432

In Melanoma, <i>RAS</i> Mutations Are Accompanied by Switching Signaling from BRAF to CRAF and Disrupted Cyclic AMP Signaling

Nicolas Dumaz, Robert Hayward, Jan Martin,

Cancer Research

2006

307

Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A

Imanol Arozarena, Berta Sanchez‐Laorden, Leisl Packer,

Cancer Cell

2011

208

Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies

Steven R. Whittaker, Robert Hayward, Alfonso Zambon,

Science Translational Medicine

2010

155

Metformin Accelerates the Growth of BRAFV600E-Driven Melanoma by Upregulating VEGF-A

Matthew J. Martin, Robert Hayward, Amaya Virós,

Cancer Discovery

2012

144

Tumor Necrosis Factor-α Blocks Apoptosis in Melanoma Cells when BRAF Signaling Is Inhibited

Vanessa C. Gray‐Schopfer, Maria Karasarides, Robert Hayward,

Cancer Research

2007

127

Nilotinib and MEK Inhibitors Induce Synthetic Lethality through Paradoxical Activation of RAF in Drug-Resistant Chronic Myeloid Leukemia

Leisl Packer, Sareena Rana, Robert Hayward,

Cancer Cell

2011

123

Extracellular Matrix Proteomics Reveals Interplay of Aggrecan and Aggrecanases in Vascular Remodeling of Stented Coronary Arteries

Gonca Suna, Wojciech Wojakowski, Marc Lynch,

Circulation

2017

104

Page 1